Andelyn Biosciences and Amplo Biotechnology Partner to Manufacture Novel Gene Therapies for Diseases Affecting the Neuromuscular Junction
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Amplo Biotechnology, a pioneer in adeno-associated virus (AAV) regenerative medicines for neuromuscular junction (NMJ) affecting conditions. The partnership will provide scalable manufacturing of clinical-grade AAV material, leveraging Andelyn's suspension AAV Curator® platform. https://mma.prnewswire.com/media/2420707/Andelyn_Biosciences_Logo.jpg Diseases of […]